Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Trpkov

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Nephrology|October 29, 1997
Reply to Shoker et alK Trpkov, K Solez, P F Halloran
Clinical Nephrology|April 3, 1998
Recurrence of anti-GBM antibody disease twelve years after transplantation associated with de novo IgA nephropathyK Trpkov, F Abdulkareem, K Jim, et al.
Current Opinion in Nephrology and Hypertension|November 1, 1993
Pathology of kidney transplant rejectionK Solez, D Battaglia, H Fahmy, et al.
Virchows Archiv : an International Journal of Pathology|December 7, 2006
Epithelioid angiosarcoma of the bladder after irradiation for endometrioid adenocarcinomaA Kulaga, A Yilmaz, R P Wilkin, et al.
Current Opinion in Nephrology and Hypertension|February 12, 1998
Renal transplant biopsy: what does it tell?K Solez, M Afrouzian, N Pakasa, et al.
Transplantation Proceedings|February 1, 1996
The Banff classification of renal allograft pathology: where do we go from here?L Racusen, D Rayner, K Trpkov, et al.
Transplantation Proceedings|February 1, 1996
Effect of subclinical rejection on renal allograft histology and function at 6 monthsD Rush, J Jeffery, K Trpkov, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1997
Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities?K Trpkov, N Marcussen, D Rayner, et al.
The Journal of Urology|February 14, 2007
Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillanceA Ochiai, K Trpkov, A Yilmaz, et al.
Transplantation Proceedings|October 1, 1995
The Banff classification of renal allograft pathology: where do we go from here?L C Racusen, D C Rayner, K Trpkov, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Nephrology|October 29, 1997
Reply to Shoker et alK Trpkov, K Solez, P F Halloran
Clinical Nephrology|April 3, 1998
Recurrence of anti-GBM antibody disease twelve years after transplantation associated with de novo IgA nephropathyK Trpkov, F Abdulkareem, K Jim, et al.
Current Opinion in Nephrology and Hypertension|November 1, 1993
Pathology of kidney transplant rejectionK Solez, D Battaglia, H Fahmy, et al.
Virchows Archiv : an International Journal of Pathology|December 7, 2006
Epithelioid angiosarcoma of the bladder after irradiation for endometrioid adenocarcinomaA Kulaga, A Yilmaz, R P Wilkin, et al.
Current Opinion in Nephrology and Hypertension|February 12, 1998
Renal transplant biopsy: what does it tell?K Solez, M Afrouzian, N Pakasa, et al.
Transplantation Proceedings|February 1, 1996
The Banff classification of renal allograft pathology: where do we go from here?L Racusen, D Rayner, K Trpkov, et al.
Transplantation Proceedings|February 1, 1996
Effect of subclinical rejection on renal allograft histology and function at 6 monthsD Rush, J Jeffery, K Trpkov, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1997
Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities?K Trpkov, N Marcussen, D Rayner, et al.
The Journal of Urology|February 14, 2007
Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillanceA Ochiai, K Trpkov, A Yilmaz, et al.
Transplantation Proceedings|October 1, 1995
The Banff classification of renal allograft pathology: where do we go from here?L C Racusen, D C Rayner, K Trpkov, et al.
Pageof 2